On January 21, the Supreme Court heard arguments in a case addressing who may challenge Food and Drug Administration (FDA) ...

At oral arguments earlier this week the Supreme Court was skeptical of the Food and Drug Administration’s effort to block a North Carolina-based company from challenging the denial of its application ...

R.J. Reynolds sought to challenge the denial in court so the company could start marketing a new menthol-flavored vape product called Vuse Alto. There was just one problem: The FSPTCA allows ...

Similarly, Vuse, BTI's vape product line, saw issues with illicit single use products in the US, but saw increased enforcement improving the flowback rate, which is encouraging: Global value share ...

R.J. Reynolds had sought to challenge one such denial in court for a new menthol-flavored vape product called Vuse Alto, but the Family Smoking Prevention and Tobacco Control Act only allows ...

The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...

Overall revenue was down 5.2% to $32.24 billion, which reflected primarily a reduction in fiscal 2024 revenue following BAT's 2023 divestitures of business in Russia and Belarus in response to ...

The FDA says vaping companies are improperly gaming the court system, filing claims in an appeals court they think will be sympathetic to them.

Altria Group Inc. chief executive Billy Gifford told tobacco analysts it "has become clear that two markets exist in the U.S.